1. Home
  2. BRBI vs IMRX Comparison

BRBI vs IMRX Comparison

Compare BRBI & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BRBI BR Partners S.A. ADSs

BRBI

BRBI BR Partners S.A. ADSs

N/A

Current Price

$11.36

Market Cap

293.2M

Sector

Finance

ML Signal

N/A

Logo Immuneering Corporation

IMRX

Immuneering Corporation

N/A

Current Price

$4.57

Market Cap

313.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BRBI
IMRX
Founded
2009
2008
Country
Brazil
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
293.2M
313.8M
IPO Year
2025
2021

Fundamental Metrics

Financial Performance
Metric
BRBI
IMRX
Price
$11.36
$4.57
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$17.20
AVG Volume (30 Days)
930.0
632.6K
Earning Date
05-08-2026
05-04-2026
Dividend Yield
5.03%
N/A
EPS Growth
N/A
37.75
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$17.24
N/A
P/E Ratio
$11.72
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.09
$3.86
52 Week High
$67.01
$10.08

Technical Indicators

Market Signals
Indicator
BRBI
IMRX
Relative Strength Index (RSI) 53.80 40.82
Support Level $10.90 $4.49
Resistance Level $11.97 $5.32
Average True Range (ATR) 0.11 0.20
MACD 0.28 -0.07
Stochastic Oscillator 94.34 13.54

Price Performance

Historical Comparison
BRBI
IMRX

About BRBI BRBI BR Partners S.A. ADSs

BRBI BR Partners SA, formerly BR Advisory Partners Participacoes SA, is engaged in investing in other companies, domestic or foreign, as a partner, quota holder, or shareholder, and management of its assets. It has a single reportable segment being investment banking services, which are administered and managed according to the products offered. However, the company divides it's operations into the following business lines: (1) investment banking and capital markets, (2) treasury sales & structuring, (3) investments and wealth management and (4) capital remuneration.

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Share on Social Networks: